Log in
TSE:VRX

Valeant Pharmaceuticals International, Inc. (VRX.TO) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.23 million shs
Average Volume1.38 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Valeant Pharmaceuticals International, Inc. operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The Bausch + Lomb/International segment provides pharmaceutical products, OTC products, and medical device products, primarily consist of Bausch + Lomb products, with a focus on the vision care, surgical, consumer, and ophthalmology Rx products in the United States; and pharmaceutical products, generic pharmaceutical products, OTC products, medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia and New Zealand, Latin America, Africa, and the Middle East. The Branded Rx segment sells gastrointestinal and dermatological products in the United States. The U.S. Diversified Products segment offers pharmaceutical products, OTC products, and medical device products in the areas of neurology and certain other therapeutic classes, including aesthetics. The company was founded in 1983 and is headquartered in Laval, Canada.
Read More
Valeant Pharmaceuticals International, Inc. (VRX.TO) logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-514-7446792
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableOptionable
30 days | 90 days | 365 days | Advanced Chart

Receive VRX News and Ratings via Email

Sign-up to receive the latest news and ratings for VRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Valeant Pharmaceuticals International, Inc. (VRX.TO) (TSE:VRX) Frequently Asked Questions

Who are some of Valeant Pharmaceuticals International, Inc. (VRX.TO)'s key competitors?

What other stocks do shareholders of Valeant Pharmaceuticals International, Inc. (VRX.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Valeant Pharmaceuticals International, Inc. (VRX.TO) investors own include Intact Financial Co. (IFC.TO) (IFC), Constellation Software Inc. (CSU.TO) (CSU), AutoCanada Inc. (ACQ.TO) (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Toronto-Dominion Bank (TD).

Who are Valeant Pharmaceuticals International, Inc. (VRX.TO)'s key executives?

Valeant Pharmaceuticals International, Inc. (VRX.TO)'s management team includes the following people:
  • Mr. Joseph C. Papa, CEO & Chairman (Age 63)
  • Mr. Paul S. Herendeen, Exec. VP & CFO (Age 62)
  • Ms. Christina M. Ackermann, Exec. VP & Gen. Counsel (Age 53)
  • Mr. Thomas J. Appio, Exec. VP & Group Chairman of International (Age 56)
  • Mr. William D. Humphries, Exec. VP & Group Chairman of Dermatology (Age 52)

What is Valeant Pharmaceuticals International, Inc. (VRX.TO)'s stock symbol?

Valeant Pharmaceuticals International, Inc. (VRX.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "VRX."

How do I buy shares of Valeant Pharmaceuticals International, Inc. (VRX.TO)?

Shares of VRX and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is Valeant Pharmaceuticals International, Inc. (VRX.TO)?

Valeant Pharmaceuticals International, Inc. (VRX.TO) has a market capitalization of C$0.00.

What is Valeant Pharmaceuticals International, Inc. (VRX.TO)'s official website?

The official website for Valeant Pharmaceuticals International, Inc. (VRX.TO) is www.valeant.com.

How can I contact Valeant Pharmaceuticals International, Inc. (VRX.TO)?

Valeant Pharmaceuticals International, Inc. (VRX.TO)'s mailing address is 2150 Saint-Elzear Blvd W, LAVAL, QC H7L 4A8, Canada. The specialty pharmaceutical company can be reached via phone at +1-514-7446792.

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.